US Bancorp
CABA icon

US Bancorp’s Cabaletta Bio CABA Stock Holding History

US Bancorp’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.3K Buy
+16,493
New +$54.2K ﹤0.01% 2775
2024
Q4 		– Sell
-191
Closed -$902 – 4170
2024
Q3 		$902 Sell
191
-226
-54% -$1.31K ﹤0.01% 3903
2024
Q2 		$3.12K Buy
417
+143
+52% +$1.75K ﹤0.01% 3623
2024
Q1 		$4.67K Hold
274
– – ﹤0.01% 3541
2023
Q4 		$6.22K Buy
+274
New +$4.61K ﹤0.01% 3459
2021
Q4 		– Sell
-900
Closed -$11K – 4104
2021
Q3 		$11K Hold
900
– – ﹤0.01% 3392
2021
Q2 		$8K Hold
900
– – ﹤0.01% 3471
2021
Q1 		$10K Hold
900
– – ﹤0.01% 3276
2020
Q4 		$11K Hold
900
– – ﹤0.01% 3136
2020
Q3 		$10K Buy
900
+600
+200% +$6.9K ﹤0.01% 3069
2020
Q2 		$3K Buy
+300
New +$2.3K ﹤0.01% 3419

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

US Bancorp's CABA Position: Q2 2026 in Review

US Bancorp opened a new position in Cabaletta Bio (CABA) in Q2 2026: 16,493 shares worth $51.3K. The stake represents ﹤0.01% of the portfolio and ranks #2775 among its holdings. This is a return to the name: US Bancorp previously reported a position in CABA as recently as Q3 2024.

US Bancorp first reported a position in CABA in Q2 2020 and has held it in 11 quarters since. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • US Bancorp held 16,493 shares of Cabaletta Bio worth $51.3K as of Q2 2026.
  • Cabaletta Bio was a new US Bancorp position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2775 holding.
  • US Bancorp first reported a position in Cabaletta Bio in Q2 2020 and has held it in 11 quarters since.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.